KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Times Interest Earned (2023 - 2025)

Travere Therapeutics (TVTX) has disclosed Times Interest Earned for 7 consecutive years, with -$15.05 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Times Interest Earned rose 29.73% year-over-year to -$15.05, compared with a TTM value of -$5.87 through Dec 2025, up 79.69%, and an annual FY2025 reading of -$5.87, up 79.69% over the prior year.
  • Times Interest Earned was -$15.05 for Q4 2025 at Travere Therapeutics, down from $8.9 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $8.9 in Q3 2025 and bottomed at -$49.73 in Q1 2024.
  • Average Times Interest Earned over 3 years is -$21.17, with a median of -$20.82 recorded in 2024.
  • Peak annual rise in Times Interest Earned hit 144.03% in 2025, while the deepest fall reached 29.73% in 2025.
  • Year by year, Times Interest Earned stood at -$33.65 in 2023, then soared by 36.34% to -$21.42 in 2024, then rose by 29.73% to -$15.05 in 2025.
  • Business Quant data shows Times Interest Earned for TVTX at -$15.05 in Q4 2025, $8.9 in Q3 2025, and -$4.44 in Q2 2025.